{"id":2914,"date":"2021-07-21T15:50:09","date_gmt":"2021-07-21T15:50:09","guid":{"rendered":"https:\/\/regensight.com\/regensight\/"},"modified":"2025-08-02T09:30:19","modified_gmt":"2025-08-02T09:30:19","slug":"regensight","status":"publish","type":"page","link":"https:\/\/regensight.com\/en\/regensight\/","title":{"rendered":"Regensight"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n

ABOUT US<\/h2>

Value proposition:
<\/span>PATIENT CENTERED AND SURGEON ORIENTED<\/span><\/h3>

We work with enthusiasm to introduce a revolutionary treatment paradigm for no-incision correction<\/strong> of the most demanding visual disorders in youth and older adults.<\/p><\/div><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t
\n \n
\n
\n <\/span>\n <\/div>\n <\/div>\n \n
\n

Mission<\/h4>\n
\n

Developing smart products for the treatment of eye disorders with significant social impact<\/p> <\/div>\n <\/div>\n <\/div>\n

\n
\n <\/div>\n <\/div>\n \n<\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n \n
\n
\n <\/span>\n <\/div>\n <\/div>\n \n
\n

Values<\/h4>\n
\n

Our values are excellence, innovation, trust and teamwork<\/p> <\/div>\n <\/div>\n <\/div>\n

\n
\n <\/div>\n <\/div>\n \n<\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tLearn More<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n \n
\n
\n <\/span>\n <\/div>\n <\/div>\n \n
\n

24\/7 Hours Support<\/h4>\n
\n

When, while the lovely valley teems with vapour around me, and the meridian sun strikes the upper surface.<\/p>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n <\/div>\n <\/div>\n \n<\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n
\n
\n \n \n\n \n \"Occhio \n <\/div>\n <\/div>\n\n<\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n

<\/h2>

Our Team<\/span><\/h3>
The startup team holds extensive know-how in medical technology and pharmaceuticals in the eye care sector.\n

The startup was founded by <\/span>Vision Engineering Italy<\/b><\/span><\/a>, a company focused on research and development of innovative products for treatment of eye diseases. Regensight is leveraging the disruptive technology developed by the parent company. <\/span><\/p><\/div><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n
\n
\"Marco<\/div> <\/div>\n
\n

Marco Lombardo<\/h4>\n

MD, PhD<\/h5>\n
\n

Marco is eye doctor and PhD in Biomedical Engineering and Computer Science.
\nHe has been devoted to treatment of visual disorders since his initial practice in ophthalmology.
\nHis life mission is to abate the need for corneal transplantation caused by keratoconus. This dream is becoming true thanks to our invention of theranostics technology!
\nMarco is a serial inventor; he holds a number of patents and has introduced several innovations in eye care, including adaptive optics ophthalmic imaging, corneal iontophoresis, scleral iontophoresis, femtosecond laser incisions for cataract surgery, advanced surface ablation techniques. He has developed ophthalmic eye drops currently in use for treating of corneal and anterior surface diseases. <\/p>\n <\/div>\n

\n